Dr Daniel Podolsky and Dr Roderick Flower have joined the board of directors of Calgary’s Antibe Therapeutics Inc, an early-stage developer of drugs for inflammatory and cardiovascular diseases. Dr Podolsky is a professor of medicine at Harvard Univ and chief of gastroenterology at Massachusetts General Hospital. He is regarded as a leading authority on inflammatory bowel disease. Dr Flower is a professor of biochemical pharmacology at the research institute of London’s Queen Mary school of medicine. He is a former principal scientist at Welcome Research Laboratories. Antibe’s research focus is on the generation of new chemical entities that improve on the parent molecules or serve unmet needs….